Torigen Pharmaceuticals
1 follower
Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.
Org chart
Ashley Kalinauskas
Collapse
Mark Suckow
Chief Technology Officer
Michael Lucroy
Chief Medical Officer
Ryan Clauson
VP of Research & Development
Sean Fitzgerald
VP of Market Development
Chelsea Greenberg
Vice President of Veterinary Affairs
Christine McCoy
External Innovation & Clinical Trial Manager
John Kallassy
Executive Advisor
Kathryn Deeley
Quality Manager
Troy Gobbett, PMP
Vice President of Operational Excellence
